FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

443011000001106: Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16250301000001116 Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
69178401000001113 Lanoxin PG 62.5microgram tablets (Aspen Pharma Trading Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Is a Product containing precisely digoxin 62.5 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Has excipient Lactose false Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Has active ingredient Digoxin false Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Is a Lanoxin PG false Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Has specific active ingredient Digoxin true Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Is a Lanoxin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) 500 tablet Is pack of False Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) 500 tablet Has AMP True Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start